Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for ADMA
| Stock Name | ADMA Biologics Inc |
| Ticker | ADMA(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US0008991046 |
Show aggregate ADMA holdings
News associated with ADMA
- Charles Schwab Investment Management Inc. Raises Position in ADMA Biologics Inc (NASDAQ:ADMA)
- Charles Schwab Investment Management Inc. boosted its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The institutional investor owned 2,462,005 shares of the biotechnology company’s stock after buying an additional 21,711 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in ADMA Biologics were worth […] - 2025-08-17 06:22:54
- PNC Financial Services Group Inc. Increases Stake in ADMA Biologics Inc (NASDAQ:ADMA)
- PNC Financial Services Group Inc. raised its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 24.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 23,325 shares of the biotechnology company’s stock after acquiring an additional 4,553 shares during the […] - 2025-08-14 04:55:07
- Harvest Fund Management Co. Ltd Takes Position in ADMA Biologics Inc (NASDAQ:ADMA)
- Harvest Fund Management Co. Ltd bought a new stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) during the first quarter, Holdings Channel reports. The fund bought 2,611 shares of the biotechnology company’s stock, valued at approximately $52,000. A number of other hedge funds and other institutional investors have also recently made changes […] - 2025-08-01 05:32:51
- ADMA Biologics Inc (NASDAQ:ADMA) Shares Acquired by Envestnet Asset Management Inc.
- Envestnet Asset Management Inc. boosted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 14.5% in the first quarter, HoldingsChannel reports. The firm owned 68,686 shares of the biotechnology company’s stock after purchasing an additional 8,682 shares during the quarter. Envestnet Asset Management Inc.’s holdings in ADMA Biologics were worth $1,363,000 […] - 2025-08-01 04:36:52
- Skandinaviska Enskilda Banken AB publ Invests $35,000 in ADMA Biologics Inc (NASDAQ:ADMA)
- Skandinaviska Enskilda Banken AB publ purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) in the first quarter, HoldingsChannel reports. The firm purchased 1,773 shares of the biotechnology company’s stock, valued at approximately $35,000. A number of other hedge funds have also modified their holdings of ADMA. Vanguard Group Inc. […] - 2025-07-31 05:57:11
- Avantax Advisory Services Inc. Has $2.15 Million Stake in ADMA Biologics Inc (NASDAQ:ADMA)
- Avantax Advisory Services Inc. lifted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 1.8% during the 1st quarter, HoldingsChannel reports. The fund owned 108,327 shares of the biotechnology company’s stock after purchasing an additional 1,954 shares during the period. Avantax Advisory Services Inc.’s holdings in ADMA Biologics were worth $2,149,000 […] - 2025-07-31 05:16:47
- Cerity Partners LLC Acquires 4,575 Shares of ADMA Biologics Inc (NASDAQ:ADMA)
- Cerity Partners LLC boosted its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 10.6% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 47,703 shares of the biotechnology company’s stock after buying an additional 4,575 shares during the quarter. Cerity Partners LLC’s holdings in ADMA Biologics were worth $946,000 as […] - 2025-07-24 04:32:54
- ADMA Biologics Inc (NASDAQ:ADMA) Shares Sold by Mutual of America Capital Management LLC
- Mutual of America Capital Management LLC lessened its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 3.9% during the 1st quarter, Holdings Channel reports. The firm owned 34,423 shares of the biotechnology company’s stock after selling 1,384 shares during the quarter. Mutual of America Capital Management LLC’s holdings in ADMA Biologics […] - 2025-07-22 07:10:54
- Bank of New York Mellon Corp Decreases Holdings in ADMA Biologics Inc (NASDAQ:ADMA)
- Bank of New York Mellon Corp cut its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 3.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,468,609 shares of the biotechnology company’s stock after selling 52,557 shares during the quarter. Bank […] - 2025-07-17 04:42:50
- ADMA Biologics Inc (NASDAQ:ADMA) Shares Acquired by Principal Financial Group Inc.
- Principal Financial Group Inc. boosted its position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 2.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,288,121 shares of the biotechnology company’s stock after purchasing an additional 29,107 […] - 2025-07-09 05:45:05
- Robeco Institutional Asset Management B.V. Boosts Holdings in ADMA Biologics Inc (NASDAQ:ADMA)
- Robeco Institutional Asset Management B.V. lifted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 48.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 258,609 shares of the biotechnology company’s stock after buying an additional 84,125 shares during the […] - 2025-07-01 05:25:03
- ADMA Biologics Inc (NASDAQ:ADMA) Shares Sold by Illinois Municipal Retirement Fund
- Illinois Municipal Retirement Fund decreased its position in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 17.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 105,223 shares of the biotechnology company’s stock after selling 21,937 shares during the period. Illinois Municipal Retirement Fund’s holdings in ADMA […] - 2025-06-30 05:38:52
- Moran Wealth Management LLC Invests $795,000 in ADMA Biologics Inc (NASDAQ:ADMA)
- Moran Wealth Management LLC purchased a new position in shares of ADMA Biologics Inc (NASDAQ:ADMA – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 40,056 shares of the biotechnology company’s stock, valued at approximately $795,000. A number of other large investors […] - 2025-06-27 05:14:54
- State of Alaska Department of Revenue Sells 3,365 Shares of ADMA Biologics Inc (NASDAQ:ADMA)
- State of Alaska Department of Revenue reduced its stake in ADMA Biologics Inc (NASDAQ:ADMA – Free Report) by 2.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 130,981 shares of the biotechnology company’s stock after selling 3,365 shares during the period. […] - 2025-06-23 04:46:52
- ADMA Biologics Inc (NASDAQ:ADMA) Director Sells $3,941,719.76 in Stock
- ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 194,749 shares of the business’s stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $20.24, for a total transaction of $3,941,719.76. Following the transaction, the director now owns 87,330 shares in the company, valued at […] - 2025-06-20 05:14:53
- Insider Selling: ADMA Biologics Inc (NASDAQ:ADMA) Director Sells 137,931 Shares of Stock
- ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) Director Steve Elms sold 137,931 shares of ADMA Biologics stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $20.82, for a total value of $2,871,723.42. Following the completion of the sale, the director now owns 282,079 shares of the […] - 2025-06-19 05:11:05
- ADMA Biologics (NASDAQ:ADMA) Stock Price Down 6.8% on Insider Selling
- ADMA Biologics Inc (NASDAQ:ADMA – Get Free Report) shares traded down 6.8% on Tuesday following insider selling activity. The company traded as low as $19.17 and last traded at $19.01. 1,700,847 shares traded hands during trading, a decline of 54% from the average session volume of 3,667,821 shares. The stock had previously closed at $20.40. […] - 2025-06-19 02:13:07
- SPYV, SAWS: Big ETF Inflows
- Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the SPDR Portfolio S&P 500 Value ETF, which added 14,400,000 units, or a 2.8% increase week over week. Among the largest underlying components of - 2025-06-11 13:09:49
- Rhumbline Advisers Buys 1,088 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
- Rhumbline Advisers raised its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.2% in the 1st quarter, Holdings Channel reports. The firm owned 622,167 shares of the biotechnology company’s stock after purchasing an additional 1,088 shares during the quarter. Rhumbline Advisers’ holdings in ADMA Biologics were worth $12,344,000 at the end […] - 2025-06-09 05:26:49
- Wellington Management Group LLP Sells 13,834 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
- Wellington Management Group LLP lessened its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 105,459 shares of the biotechnology company’s stock after selling 13,834 shares during the quarter. Wellington Management Group […] - 2025-06-06 05:04:51
- California State Teachers Retirement System Acquires 8,717 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
- California State Teachers Retirement System grew its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 4.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 217,391 shares of the biotechnology company’s stock after purchasing an additional 8,717 […] - 2025-06-05 05:33:03
- B. Riley Wealth Advisors Inc. Cuts Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)
- B. Riley Wealth Advisors Inc. lowered its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 31.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 12,614 shares of the biotechnology company’s stock after selling 5,892 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in ADMA Biologics were worth […] - 2025-06-02 05:40:55
- UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $8.77 Million Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)
- UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 511,526 shares of the biotechnology company’s stock after acquiring an additional 1,559 shares during […] - 2025-06-01 05:37:02
- ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Tidal Investments LLC
- Tidal Investments LLC lessened its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 20.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,351 shares of the biotechnology company’s stock after selling 7,983 shares during the quarter. Tidal Investments LLC’s holdings […] - 2025-05-29 05:10:54
- Janus Henderson Group PLC Acquires 15,000 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)
- Janus Henderson Group PLC raised its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 16.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 107,161 shares of the biotechnology company’s stock after purchasing an additional 15,000 shares during the period. Janus Henderson Group PLC’s […] - 2025-05-22 06:14:47
- MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.56 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA)
- MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 7.2% during the 4th quarter, Holdings Channel reports. The firm owned 148,638 shares of the biotechnology company’s stock after purchasing an additional 10,047 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in […] - 2025-05-21 06:14:52
- ADMA Biologics (NASDAQ:ADMA) Cut to Sell at StockNews.com
- StockNews.com downgraded shares of ADMA Biologics (NASDAQ:ADMA – Free Report) from a hold rating to a sell rating in a research report released on Friday morning. Other equities analysts have also issued reports about the stock. Raymond James boosted their price objective on shares of ADMA Biologics from $25.00 to $32.00 and gave the stock […] - 2025-05-12 02:52:44
- 33,419 Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) Bought by Mariner LLC
- Mariner LLC acquired a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 33,419 shares of the biotechnology company’s stock, valued at approximately $573,000. A number of other hedge funds have also added to […] - 2025-05-01 05:55:00
- Analysts Anticipate EZM Will Reach $74
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-09 07:49:44
- Vanguard Group Inc. Boosts Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)
- Vanguard Group Inc. increased its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,198,796 shares of the biotechnology company’s stock after buying an additional 80,302 shares during the quarter. Vanguard […] - 2025-04-04 05:04:57
iShares MSCI World Small Cap UCITS ETF USD (Acc) ADMA holdings
| Date | Number of ADMA Shares Held | Base Market Value of ADMA Shares | Local Market Value of ADMA Shares | Change in ADMA Shares Held | Change in ADMA Base Value | Current Price per ADMA Share Held | Previous Price per ADMA Share Held |
|---|
| 2025-11-27 (Thursday) | 178,256 | USD 3,411,820 | USD 3,411,820 | 0 | USD 0 | USD 19.14 | USD 19.14 |
| 2025-11-26 (Wednesday) | 178,256 | USD 3,411,820 | USD 3,411,820 | -335 | USD -18,913 | USD 19.14 | USD 19.21 |
| 2025-11-25 (Tuesday) | 178,591 | USD 3,430,733 | USD 3,430,733 | 0 | USD 158,946 | USD 19.21 | USD 18.32 |
| 2025-11-24 (Monday) | 178,591 | USD 3,271,787 | USD 3,271,787 | 0 | USD 203,594 | USD 18.32 | USD 17.18 |
| 2025-11-21 (Friday) | 178,591 | USD 3,068,193 | USD 3,068,193 | 0 | USD 146,444 | USD 17.18 | USD 16.36 |
| 2025-11-20 (Thursday) | 178,591 | USD 2,921,749 | USD 2,921,749 | 1,041 | USD 89,826 | USD 16.36 | USD 15.95 |
| 2025-11-19 (Wednesday) | 177,550 | USD 2,831,923 | USD 2,831,923 | 10,440 | USD 209,967 | USD 15.95 | USD 15.69 |
| 2025-11-18 (Tuesday) | 167,110 | USD 2,621,956 | USD 2,621,956 | 0 | USD 45,120 | USD 15.69 | USD 15.42 |
| 2025-11-17 (Monday) | 167,110 | USD 2,576,836 | USD 2,576,836 | 0 | USD -23,396 | USD 15.42 | USD 15.56 |
| 2025-11-14 (Friday) | 167,110 | USD 2,600,232 | USD 2,600,232 | -1,344 | USD -44,496 | USD 15.56 | USD 15.7 |
| 2025-11-13 (Thursday) | 168,454 | USD 2,644,728 | USD 2,644,728 | 0 | USD -128,025 | USD 15.7 | USD 16.46 |
| 2025-11-12 (Wednesday) | 168,454 | USD 2,772,753 | USD 2,772,753 | 0 | USD 72,435 | USD 16.46 | USD 16.03 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of ADMA by Blackrock for IE00BF4RFH31
Show aggregate share trades of ADMA| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-11-26 | SELL | -335 | 19.480 | 19.000 | 19.048 | USD -6,381 | 18.29 Loss of -254 on sale |
| 2025-11-26 | SELL | -335 | 19.480 | 19.000 | 19.048 | USD -6,381 | 18.29 Loss of -254 on sale |
| 2025-11-20 | BUY | 1,041 | 16.950 | 16.230 | 16.302 | USD 16,970 | 18.30 |
| 2025-11-19 | BUY | 10,440 | 16.030 | 15.460 | 15.517 | USD 161,997 | 18.31 |
| 2025-11-14 | SELL | -1,344 | 15.900 | 15.400 | 15.450 | USD -20,765 | 18.35 Profit of 3,901 on sale |
| 2025-10-29 | BUY | 672 | 15.530 | 15.750 | 15.728 | USD 10,569 | 18.55 |
| 2025-10-21 | BUY | 1,344 | 14.715 | 14.810 | 14.801 | USD 19,892 | 18.66 |
| 2025-10-07 | BUY | 672 | 13.990 | 14.230 | 14.206 | USD 9,546 | 18.73 |
| 2025-09-08 | SELL | -1,336 | 16.420 | 16.870 | 16.825 | USD -22,478 | 18.95 Profit of 2,836 on sale |
| 2025-08-15 | BUY | 668 | 16.990 | 17.015 | 17.012 | USD 11,364 | 18.96 |
| 2025-08-07 | BUY | 2,004 | 16.750 | 17.515 | 17.438 | USD 34,947 | 18.98 |
| 2025-07-29 | BUY | 668 | 18.260 | 18.310 | 18.305 | USD 12,228 | 18.99 |
| 2025-07-14 | BUY | 1,336 | 18.680 | 18.785 | 18.774 | USD 25,083 | 19.05 |
| 2025-06-30 | BUY | 1,336 | 18.210 | 18.915 | 18.845 | USD 25,176 | 19.09 |
| 2025-06-25 | BUY | 2,004 | 17.600 | 17.880 | 17.852 | USD 35,775 | 19.11 |
| 2025-06-20 | SELL | -336 | 17.740 | 18.193 | 18.148 | USD -6,098 | 19.14 Profit of 333 on sale |
| 2025-06-12 | SELL | -2,672 | 21.600 | 22.198 | 22.138 | USD -59,153 | 19.12 Loss of -8,076 on sale |
| 2025-06-02 | BUY | 1,008 | 20.430 | 20.440 | 20.439 | USD 20,603 | 19.02 |
| 2025-05-28 | BUY | 668 | 19.510 | 20.080 | 20.023 | USD 13,375 | 19.00 |
| 2025-05-14 | BUY | 334 | 19.470 | 19.860 | 19.821 | USD 6,620 | 18.91 |
| 2025-05-13 | BUY | 668 | 19.880 | 20.800 | 20.708 | USD 13,833 | 18.90 |
| 2025-05-07 | BUY | 1,002 | 23.610 | 23.980 | 23.943 | USD 23,991 | 18.81 |
| 2025-04-28 | BUY | 334 | 24.510 | 25.670 | 25.554 | USD 8,535 | 18.47 |
| 2025-04-16 | BUY | 4,342 | 21.230 | 22.055 | 21.973 | USD 95,405 | 18.23 |
| 2025-04-14 | BUY | 668 | 20.910 | 21.340 | 21.297 | USD 14,226 | 18.15 |
| 2025-04-08 | SELL | -668 | 17.860 | 19.490 | 19.327 | USD -12,910 | 18.12 Loss of -805 on sale |
| 2025-04-04 | SELL | -672 | 18.010 | 19.000 | 18.901 | USD -12,701 | 18.12 Loss of -525 on sale |
| 2025-03-28 | BUY | 3,340 | 20.260 | 20.630 | 20.593 | USD 68,781 | 18.03 |
| 2025-03-12 | SELL | -672 | 18.500 | 18.560 | 18.554 | USD -12,468 | 17.79 Loss of -512 on sale |
| 2025-03-04 | SELL | -672 | 17.010 | 17.075 | 17.069 | USD -11,470 | 17.84 Profit of 521 on sale |
| 2025-02-26 | SELL | -1,352 | 15.780 | 16.120 | 16.086 | USD -21,748 | 17.98 Profit of 2,556 on sale |
| 2025-02-13 | BUY | 338 | 16.080 | 16.150 | 16.143 | USD 5,456 | 18.34 |
| 2025-02-12 | BUY | 1,352 | 15.840 | 15.870 | 15.867 | USD 21,452 | 18.39 |
| 2025-01-27 | BUY | 336 | 16.190 | 16.515 | 16.482 | USD 5,538 | 19.01 |
| 2025-01-23 | BUY | 336 | 16.580 | 16.580 | 16.580 | USD 5,571 | 19.16 |
| 2024-12-09 | BUY | 12,132 | 19.010 | 19.993 | 19.895 | USD 241,363 | 19.33 |
| 2024-12-04 | BUY | 674 | 19.950 | 20.000 | 19.995 | USD 13,477 | 19.29 |
| 2024-12-03 | BUY | 1,011 | 19.920 | 20.180 | 20.154 | USD 20,376 | 19.27 |
| 2024-11-19 | BUY | 2,022 | 20.630 | 20.650 | 20.648 | USD 41,750 | 18.24 |
| 2024-11-18 | BUY | 674 | 19.540 | 19.588 | 19.583 | USD 13,199 | 18.16 |
| 2024-11-12 | BUY | 1,340 | 21.780 | 22.460 | 22.392 | USD 30,005 | 17.93 |
| 2024-11-11 | BUY | 335 | 22.480 | 23.640 | 23.524 | USD 7,881 | 17.63 |
| 2024-11-07 | BUY | 1,675 | 19.720 | 20.060 | 20.026 | USD 33,544 | 17.09 |
| 2024-10-23 | BUY | 670 | 15.690 | 15.760 | 15.753 | USD 10,555 | 15.64 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of ADMA
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 554,413 | 737 | 1,447,505 | 38.3% |
| 2025-09-18 | 435,181 | 10,124 | 1,445,628 | 30.1% |
| 2025-09-17 | 543,908 | 2,280 | 876,530 | 62.1% |
| 2025-09-16 | 737,803 | 539 | 1,354,532 | 54.5% |
| 2025-09-15 | 675,632 | 2,599 | 1,376,964 | 49.1% |
| 2025-09-12 | 712,792 | 898 | 1,337,204 | 53.3% |
| 2025-09-11 | 245,175 | 51 | 674,953 | 36.3% |
| 2025-09-10 | 472,172 | 2,282 | 1,124,270 | 42.0% |
| 2025-09-09 | 884,089 | 1,100 | 1,519,252 | 58.2% |
| 2025-09-08 | 766,409 | 1,658 | 1,629,503 | 47.0% |
| 2025-09-05 | 645,121 | 53 | 1,156,332 | 55.8% |
| 2025-09-04 | 900,160 | 6,750 | 2,273,752 | 39.6% |
| 2025-09-03 | 1,231,947 | 1,355 | 2,927,053 | 42.1% |
| 2025-09-02 | 810,257 | 1,236 | 2,109,450 | 38.4% |
| 2025-08-29 | 303,289 | 6,797 | 702,329 | 43.2% |
| 2025-08-28 | 274,561 | 1,158 | 997,208 | 27.5% |
| 2025-08-27 | 503,270 | 954 | 1,369,101 | 36.8% |
| 2025-08-26 | 256,012 | 0 | 578,123 | 44.3% |
| 2025-08-25 | 513,545 | 2,143 | 940,749 | 54.6% |
| 2025-08-22 | 377,885 | 799 | 825,861 | 45.8% |
| 2025-08-21 | 199,294 | 182 | 788,296 | 25.3% |
| 2025-08-20 | 360,602 | 1,094 | 570,043 | 63.3% |
| 2025-08-19 | 453,129 | 411 | 860,623 | 52.7% |
| 2025-08-18 | 528,897 | 4,279 | 1,092,008 | 48.4% |
| 2025-08-15 | 578,165 | 267 | 914,924 | 63.2% |
| 2025-08-14 | 587,513 | 1,054 | 927,272 | 63.4% |
| 2025-08-13 | 567,780 | 462 | 1,138,209 | 49.9% |
| 2025-08-12 | 674,254 | 0 | 2,086,060 | 32.3% |
| 2025-08-11 | 1,452,382 | 300 | 3,031,830 | 47.9% |
| 2025-08-08 | 810,291 | 45,406 | 1,626,478 | 49.8% |
| 2025-08-07 | 3,063,753 | 85,414 | 5,058,742 | 60.6% |
| 2025-08-06 | 655,276 | 128 | 1,327,472 | 49.4% |
| 2025-08-05 | 428,337 | 955 | 888,079 | 48.2% |
| 2025-08-04 | 446,905 | 400 | 948,770 | 47.1% |
| 2025-08-01 | 502,020 | 917 | 776,356 | 64.7% |
| 2025-07-31 | 398,016 | 208 | 690,219 | 57.7% |
| 2025-07-30 | 628,331 | 1,909 | 1,119,597 | 56.1% |
| 2025-07-29 | 559,011 | 1,732 | 873,518 | 64.0% |
| 2025-07-28 | 537,514 | 318 | 921,685 | 58.3% |
| 2025-07-25 | 495,317 | 480 | 1,415,367 | 35.0% |
| 2025-07-24 | 389,617 | 1,948 | 699,976 | 55.7% |
| 2025-07-23 | 383,783 | 4,230 | 1,967,701 | 19.5% |
| 2025-07-22 | 363,559 | 3,539 | 788,351 | 46.1% |
| 2025-07-21 | 437,901 | 4,001 | 781,019 | 56.1% |
| 2025-07-18 | 518,685 | 5,237 | 1,840,212 | 28.2% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.